"RDIF and GL Rapha, one of South Korea's leading biotechnology companies (including its subsidiary Hankook Korus Pharm), are announcing an agreement to produce more than 150 million doses of the world's first registered Sputnik V coronavirus vaccine in the country," the agency said. fund message.
Production is scheduled to start in December, and export deliveries of the vaccine are planned for January 2021.
“Currently, there is a need to develop international cooperation and partnerships to ensure sufficient supply of Sputnik V vaccine and to meet international demand.
We would like to thank our partners from GL Rapha for their cooperation and joining efforts, ”said Kirill Dmitriev, head of RDIF.
Earlier, the WHO said that the organization will add the Russian Sputnik V coronavirus vaccine to the list of recommended for emergency use, if it meets the necessary criteria.